August 4, 2015
Recommended Topic Related To:

Macugen

"The US Food and Drug Administration (FDA) has approved Akorn Inc's phenylephrine hydrochloride ophthalmic solution (2.5% and 10%), the company has announced.

The alpha-1 adrenergic receptor agonist is commonly used by optometrists, ophtha"...

Macugen




PATIENT INFORMATION

In the days following Macugen administration, patients are at risk for the development of endophthalmitis. If the eye becomes red, sensitive to light, painful or develops a change in vision, the patient should seek the immediate care with their ophthalmologist [see WARNINGS AND PRECAUTIONS].

Last reviewed on RxList: 10/28/2011
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.